Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder

Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder is a paper indexed in PICO Portal from OpenAlex.

How many citations does Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder have?

Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder has 0 citations in the OpenAlex counts PICO Portal stores.

When was Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder published?

Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder has 2025 year in the PICO Portal index.

What is the open-access status of Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder?

Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder has diamond oa status in the PICO Portal index.

What is the DOI of Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder?

The DOI for Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder is on the source record.

What is the OpenAlex record for Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder?

The OpenAlex for Optimizing conservative management on recurrent hypotony maculopathy following glaucoma drainage devices implantation in steroid responder is on the source record.